Botanical species · safety record
Tribulus terrestris
The EFSA Compendium of Botanicals holds 16 constituent measurements and 9 adverse-effect records for Tribulus terrestris. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Tribulus terrestris L.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 1,031 licensed products naming Tribulus terrestris as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Harmalol2
- Harmane alkaloids2
- Calcium oxalate1
- Carboline alkaloids1
- Cyanide1
- Harmol1
- Moupinamide1
- N-p-coumaroyltyramine1
- Nitrate1
- Nitrites1
Plant parts
- Unspecified18
- Leaves5
- Fruit unspecified1
Preparations
- Solvent extraction13
Effect types
- Digestive2
- Hepatotoxicity2
- Neurotoxicity2
- Hemopoietic1
- Nephrotoxicity1
- Pulmonary and cardiac1
Target tissues
- Cardiovascular2
- Urogenital: kidneys2
- haematological2
- Digestive1
- Digestive: pancreas1
- Liver1
- Muscle, skeletal1
- Neurologic1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Moupinamide | Unspecified | Solvent extraction | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| N-p-coumaroyltyramine | Unspecified | Solvent extraction | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Phenylpropanoids | Unspecified | Solvent extraction | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Calcium oxalate | Leaves | Solvent extraction | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | No resolvable identifier |
| Carboline alkaloids | Unspecified | Solvent extraction | — | Chromatographic tests | No resolvable identifier |
| Cyanide | Leaves | — | 14.4 ppm | Colorimetry, Spectroscopy (Spectrometry) and Photometry | No resolvable identifier |
| Harmalol | Unspecified | Solvent extraction | ≥ 414 Nanogram/gram | Chromatographic tests | No resolvable identifier |
| Harmalol | Unspecified | Solvent extraction | ≤ 486 Nanogram/gram | Chromatographic tests | No resolvable identifier |
| Harmane alkaloids | Unspecified | Solvent extraction | ≤ 143 Nanogram/gram | Chromatographic tests | No resolvable identifier |
| Harmane alkaloids | Unspecified | Solvent extraction | ≥ 75.2 Nanogram/gram | Chromatographic tests | No resolvable identifier |
| Harmol | Unspecified | Solvent extraction | ≤ 453 Nanogram/gram | Chromatographic tests | No resolvable identifier |
| Nitrate | Leaves | — | 15.28 Milligram/gram | Colorimetry, Spectroscopy (Spectrometry) and Photometry | No resolvable identifier |
| Nitrites | Leaves | — | 9.71 Milligram/gram | Colorimetry, Spectroscopy (Spectrometry) and Photometry | No resolvable identifier |
| Norharmane | Unspecified | Solvent extraction | 96.2 Nanogram/gram | Chromatographic tests | No resolvable identifier |
| Oxalates | Leaves | — | 0.14 Percent | Colorimetry, Spectroscopy (Spectrometry) and Photometry | No resolvable identifier |
| Saponins | Fruit unspecified | Solvent extraction | — | Unspecified | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Digestive | Digestive: pancreas | Unspecified | Solvent extraction | — | In vitro | Resolve DOI |
| Digestive | Digestive | Unspecified | — | Goat (as animal) | Subchronic | Resolve DOI |
| Hemopoietic | Cardiovascular / haematological | Unspecified | — | Goat (as animal) | Subchronic | Resolve DOI |
| Hepatotoxicity | Liver | Unspecified | — | Human (as organism) | Case report | Resolve DOI |
| Hepatotoxicity | Urogenital: kidneys | Unspecified | — | Goat (as animal) | Subchronic | Resolve DOI |
| Nephrotoxicity | Urogenital: kidneys | Unspecified | — | Human (as organism) | Case report | Resolve DOI |
| Neurotoxicity | Neurologic | Unspecified | — | Human (as organism) | Case report | Resolve DOI |
| Neurotoxicity | Muscle, skeletal | — | — | Sheep (as animal) | Other | Resolve DOI |
| Pulmonary and cardiac | Cardiovascular / haematological | Unspecified | — | Goat (as animal) | Subchronic | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Hemalatha, S., Hari, R. Acute and subacute toxicity studies of the saponin rich butanol extracts of tribulus terrestris fruits in wistar rats. International journal of pharmaceutical sciences review and research, 2014, vol. 27, no. 2, p. 307-313.
- Song, Yeong Hun., Kim, Dae Wook., Curtis-Long, Marcus J., Park, Chanin., Son, Minky., Kim, Jeong Yoon., Yuk, Heung Joo., Lee, Keun Woo., Park, Ki Hun. Cinnamic acid amides from Tribulus terrestris displaying uncompetitive alpha-glucosidase inhibition . European journal of medicinal chemistry, 2016, vol. 114, p. 201-208. DOI
- Aslani, MR., Movassaghi, AR., Mohri, M., Ebrahim-Pour, V., Mohebi, AN. Experimental Tribulus terrestris poisoning in goats. Small ruminant research, 2004, vol. 51, no. 3, p. 261-267. DOI
- Talasaz, Azita Hajhossein., Abbasi, Mohammad-Reza., Abkhiz, Saeed., Dashti-Khavidaki, Simin. Tribulus terrestris-induced severe nephrotoxicity in a young healthy male . Nephrology dialysis transplantation, 2010, vol. 25, no. 11, p. 3792-3793. DOI
- Bourke, CA. Abnormal turning behaviour, GABAergic inhibition and the degeneration of astrocytes in ovine Tribulus terrestris motor neuron disease . Australian veterinary journal, 2006, vol. 84, no. 1-2, p. 53-58. DOI
- Tsuchiya, Hironori., Hayashi, Hideaki., Sato, Masaru., Shimizu, Hiroshi., Iinuma, Munekazu. Quantitative analysis of all types of beta-carboline alkaloids in medicinal plants and dried edible plants by high performance liquid chromatography with selective fluorometric detection. Phytochemical analysis, 1999, vol. 10, no. 5, p. 247-253.
- Tutuncu Konyar, Sevil., Ozturk, Necla., Dane, Feruzan. Occurrence, types and distribution of calcium oxalate crystals in leaves and stems of some species of poisonous plants. Botanical studies, 2014, vol. 55, no. 1, p. 1-9.
- Abatan, M. O., Arowolo, R. O., Olurunsogo, O. O. Phytochemical analysis of some commonly occurring poisonous plants in Nigerian pastures . Tropical veterinarian, 1997, vol. 15, no. 1-2, p. 49-54.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.